Including :
Strategic overview Ip developments Policy review
Including:
Biosimilars Big pharma and generics Product differentiation and focus International market focus
Improving profitability in difficult times
Development and commercialisation framework for biosimilars
Register for World Generic Medicines Congress Europe 2012 ›
Get the World Generic Medicines Congress Europe 2012 brochure ›
Register now! ›
sponsor World Generic Medicines Congress Europe 2012 ›
sponsors list ›